skip to main content

S. 292 (115th): Childhood Cancer Survivorship, Treatment, Access, and Research Act of 2018

We don’t have a summary available yet.

The summary below was written by the Congressional Research Service, which is a nonpartisan division of the Library of Congress, and was published on Jun 6, 2018.

Childhood Cancer Survivorship, Treatment, Access, and Research Act of 2018 or the Childhood Cancer STAR Act


Subtitle A--Caroline Pryce Walker Conquer Childhood Cancer Reauthorization Act (Sec. 101) This bill amends the Public Health Service Act to authorize the National Institutes of Health (NIH) to provide support to collect the medical specimens and information of children, adolescents, and young adults with selected cancers that have the least effective treatments in order to achieve a better understanding of these cancers and the effects of treatment.

(Sec. 102) The national childhood cancer registry is reauthorized through FY2023 and revised to authorize the Centers for Disease Control and Prevention to award grants to state cancer registries to improve tracking of childhood cancers.

Subtitle B--Pediatric Expertise at NIH

(Sec. 111) The bill requires at least one member of the National Cancer Advisory Board, which advises the National Cancer Institute, to be knowledgeable in pediatric oncology.

Subtitle C--NIH Reporting on Childhood Cancer Activities

(Sec. 121) The NIH must ensure that information about supported childhood cancer research projects is included in appropriate congressional reports, including the Pediatric Research Initiative report.


(Sec. 201) The Department of Health and Human Services (HHS) may support pilot programs to develop or study models for monitoring and caring for childhood cancer survivors throughout their lives.

HHS must also review departmental activities relating to workforce development for health care providers who treat pediatric cancer patients and survivors.

(Sec. 202) The NIH may continue to support research relating to pediatric cancer survivorship, including outcomes for, and barriers faced by, pediatric cancer survivors within minority or medically underserved populations.

(Sec. 203) HHS may also support the development of best practices regarding childhood and adolescent cancer survivorship care.